We hypothesized that the AM-RAMP2 system could have therapeutic value in uveitis, considering that the condition involves abnormal autoimmune responses and shares inflammatory and vascular permeability features with RVO and AMD. The gene discussed is RAMP2; the disease is age-related macular degeneration.